R. Lizak

Insider Reports History

Location
201 Mission Street, Suite 2375, San Francisco, CA
Signature
/s/ Carlol R. Lizak
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R. Lizak:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jaguar Health, Inc. Chief Financial Officer Common Stock 4.3K $18.00 $0.03 Oct 8, 2024 Direct
Jaguar Health, Inc. Chief Financial Officer Common Stock 1 $3.00 $0.03 Oct 8, 2024 Indirect
Jaguar Health, Inc. Chief Financial Officer Restricted stock units 431 $0 $0.03 May 17, 2024 Direct
Jaguar Health, Inc. Chief Financial Officer Stock option (right to buy) 34.2K Oct 8, 2024 Direct
Jaguar Health, Inc. Chief Financial Officer Convertible Promissory Note 5.4K Mar 31, 2025 Direct
Jaguar Health, Inc. Chief Financial Officer Warrant to Purchase Common Stock 5.4K Mar 31, 2025 Direct

Insider Reports Filed by R. Lizak

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JAGX Jaguar Health, Inc. Mar 31, 2025 2 $162M 4 Apr 2, 2025 Chief Financial Officer
JAGX Jaguar Health, Inc. Oct 8, 2024 2 $0 4 Oct 10, 2024 Chief Financial Officer
JAGX Jaguar Health, Inc. May 17, 2024 2 $0 4 May 21, 2024 Chief Financial Officer
JAGX Jaguar Health, Inc. Apr 5, 2024 2 $0 4 Apr 17, 2024 Chief Financial Officer
JAGX Jaguar Health, Inc. Aug 14, 2023 1 $0 4 Aug 14, 2023 Chief Financial Officer
JAGX Jaguar Health, Inc. May 17, 2023 2 $0 4 May 19, 2023 Chief Financial Officer
JAGX Jaguar Health, Inc. Apr 5, 2023 2 $0 4 Apr 20, 2023 Chief Financial Officer
JAGX Jaguar Health, Inc. Dec 27, 2022 1 $0 4 Dec 28, 2022 Chief Financial Officer
JAGX Jaguar Health, Inc. Apr 5, 2022 2 $0 4 Apr 6, 2022 Chief Financial Officer
JAGX Jaguar Health, Inc. Sep 13, 2021 2 $20K 4 Mar 30, 2022 Chief Financial Officer